immunitoAI, a biotech startup that is developing an AI-powered antibody discovery and screening platform, announced that it has raised $1 million in a seed round led by Pi Ventures, with existing investor Entrepreneur First also participating. This is pi Ventures’s first investment from their Fund 2, announced in April 2021.
According to the official statement, the funds raised by the startup will be deployed for product development and industry partnerships.
